Why couch potatoes will likely remain couch potatoes

Research conducted by scientists at the Oregon National Primate Research Center at Oregon Health & Science University reveals that a person’s level of activity is likely an intrinsic property of that individual. This means personal decisions to become more active for the purpose of losing weight may take more of a conscious effort than traditionally thought for certain people. The research is being presented during the Society for Neuroscience meeting in Washington, D.C., Nov. 12-16. It is one of the largest and most respected meetings of neuroscientists in the world.

Q&A with a Lung Cancer Survivor

Grateful. That’s the word Susan Nelson, a 52-year-old Temecula teacher, uses over and over again in conversation. And no wonder — Nelson has successfully battled lung cancer for 17 years, in the process participating in many of the most experimental drug treatments. We were first introduced to Susan’s story by a July 28, 2002 article in the Los Angeles Times: In 1989, she was diagnosed with bronchoalveolar carcinoma, a slow-growing lung cancer. Doctors removed a portion of her right lung, but the cancer recurred in 1994. Described as “an athletic woman who never smoked,” Susan was, at the time of the article, enrolled in a clinical trial testing the effectiveness of Iressa. More than three years later, reporter Emmanuelle Richard caught up with this upbeat and inspiring woman, and talked about her latest clinical trial, for a lung cancer vaccine.

Nicotine vaccine has promise for helping smokers quit

A University of Minnesota study indicates that the nicotine vaccine NicVax, which is now being tested in humans, appears safe, well-tolerated, and a potentially effective method for helping smokers kick the habit. The 38-week study included 68 active smokers who were randomly assigned to receive one of three different doses of the vaccine or a placebo. The findings are published in the current issue of the journal Clinical Pharmacology and Therapeutics.

Synaptic connections need nurturing to retain their structure and keep outsiders at bay

The ability of the brain to transmit and process information requires a lifelong commitment to maintaining the integrity of synapses — the special connections that permit the passage of nerve impulses from one nerve cell to another, according to investigators at St. Jude Children’s Research Hospital and colleagues in Hokkaido University School of Medicine.

Abbr. Collection

The collection of abbreviation, especialy about Computer Science.
For example:
ISO International Organization for Standardization
Abbr. Abbreviation
SC Subcommittee
…

Major study links chronic noise exposure to risk of heart attacks

Research published in European’s leading cardiology journal, European Heart Journal, links exposure to chronic noise with an increased risk of heart attack. Furthermore, the risk seems to be associated more with the physiological effect of environmental and work noise than with the annoyance it causes individuals, although there are differences in effects between men and women.

Family habits set drinking path

Teenagers are more likely to develop drinking problems if their mothers are depressed and drink regularly. The findings come from University of Queensland researchers who tracked alcohol related disorders of children through adulthood as part of one of the world’s longest health studies.

Electrons ‘tunnel’ through water molecules between nestled proteins

Theoretical chemists who spend much of their time calculating how the exotic rules of quantum mechanics govern electrons motion between and through biological molecules have garnered surprising results when they add water to their models. They have discovered that a scant handful of water molecules positioned in the nearly infinitesimal gap between two “docking” proteins creates unexpectedly favorable conditions for electrons to “tunnel” from one protein to another.

HIV inserts into human genome using a DNA-associated protein

A human DNA-associated protein called LEDGF is the first such molecule found to control the location of HIV integration in human cells, according to a new study from researchers at the University of Pennsylvania School of Medicine. This study, published in this week’s early online edition of Nature Medicine, describes the first clear target for modulating where viruses insert into the human genome, which has implications for better design of gene-therapy delivery. Retroviral vectors are often used to introduce therapeutic genetic sequences into human chromosomes, such as in the delivery of Factor VIII for hemophilia patients.

DRUG STOPS MULTIPLE SCLEROSIS – BUT SUFFERERS CAN’T GET IT

Through my website I became aware of a drug that has stopped the progression of Multiple Sclerosis and enhanced the quality of life of many Multiple Sclerosis (MS) sufferers.

The drug is Naltrexone (also known as ReVia) and my ‘Health Success Stories’ database contains a growing body of compelling anecdotal evidence that Low Dose Naltrexone (LDN) works, and; it works well – BUT, sufferers can’t get it.

Naltrexone has not achieved mainstream acceptance as a treatment option for MS due to absence of clinical trial data. Research, drug development, and clinical trials are commercially-driven by sponsors. That’s okay, but there’s no recognized body that can officially step up to the plate to speak and act on behalf of patients. I know this because I’ve tried, without success, to find an authority that is sanctioned to do so.

The present system is unjust. It’s inequitable. It doesn’t place sufficient value on patient health success stories. It doesn’t place sufficient value on advocating for the patient. It doesn’t place sufficient value on patient-driven research or clinical trials. If it did, there would be a body sanctioned to speak and act on a promising body of testimonials.

How many stories similar to the LDN story are out there? We don’t know, because they haven’t all been collected, stored, and shared. That makes me feel uneasy and should make you feel uneasy.

We need an organisation chartered to act on this type of evidence; an organisation that values patient testimony and can make recommendations (without prejudice) on behalf of patients from all corners of the globe.